Phenotype-Based Cardiometabolic Risk Profiles in Older Adults: German Ärzteblatt News
Study Validates Risk Groups for Cardiometabolic Issues in Older Adults
Table of Contents
- Study Validates Risk Groups for Cardiometabolic Issues in Older Adults
- Specialist Areas:
- Understanding Cardiometabolic Risk in Older Adults: A Q&A
- What are cardiometabolic issues?
- What’s the significance of this new study?
- Who led the research and where was it conducted?
- What are the key findings of the Kora F4 study?
- Where was the study published?
- How does this research help older adults?
- Where can I find out more about these risk groups?
- What are the areas of expertise related to this research?
- Summary of Key Information
DÜSSELDORF, Germany — Research conducted five years ago by a study group led by Robert Wagner, head of teh Clinical Study Center at the University Hospital Düsseldorf’s Institute for Clinical Diabetology, identified six distinct risk groups, or clusters, susceptible to cardiometabolic complications in the absence of diabetes.
Now, findings from the Kora F4 study (cooperative health research in the Augsburg region) have confirmed the validity of these clusters in an older population. The study, involving 843 participants aged 61–82 without diabetes, demonstrated that the previously identified risk groups remain relevant in older individuals. The findings were published in Cardiovascular Diabetology,2025; DOI: 10.1186/S1293-025-02617-8.
Understanding Cardiometabolic Risk in Older Adults: A Q&A
by AI Assistant
this article explores the importance of recent research on cardiometabolic risk factors in older adults. We’ll delve into the findings of a study that validates the identification of specific risk groups, providing valuable insights for individuals and healthcare professionals alike.
What are cardiometabolic issues?
Cardiometabolic issues refer to a range of interconnected health problems that increase the risk of cardiovascular disease, type 2 diabetes, and stroke. These issues often involve metabolic dysfunction, such as high blood pressure, high cholesterol, insulin resistance, and excess abdominal fat.
What’s the significance of this new study?
The study,based on the Kora F4 study,confirms that risk groups for cardiometabolic complications,originally identified in middle-aged populations,are also relevant and applicable to older adults. This means that the same clusters of individuals at higher risk can be identified even in those aged 61-82, providing a vital tool for targeted interventions and preventative strategies.
Who led the research and where was it conducted?
Robert Wagner, head of the Clinical Study Center at the university Hospital Düsseldorf’s Institute for Clinical Diabetology, led the initial research that identified these risk groups. the Kora F4 study, which validated these findings in older adults, is a cooperative health research project in the Augsburg region of Germany.
What are the key findings of the Kora F4 study?
The Kora F4 study validated the existence of six distinct risk groups, or clusters, for cardiometabolic complications in an older population of 843 participants aged 61–82 without diabetes. This confirms the relevance of these previously identified risk groups in older individuals.
Where was the study published?
The findings were published in Cardiovascular Diabetology in 2025. The DOI is 10.1186/S1293-025-02617-8.
How does this research help older adults?
By identifying individuals belonging to specific risk groups, healthcare providers can tailor interventions and lifestyle recommendations. Early detection allows for proactive management of risk factors, potentially preventing the onset of serious health problems.
Where can I find out more about these risk groups?
While the source article identifies that there are six distinct risk groups, it does not provide specifics. It is essential to speak with your physician. They can provide additional insights into these clusters, along with the most helpful steps for you to take to manage your health.
The specialists involved in this research frequently include:
Endocrinology and Diabetology: Specialists in hormones and metabolic disorders.
Cardiology: Specialists in the heart and blood vessels.
Summary of Key Information
Here’s a summary of the main points:
| Aspect | Details |
|---|---|
| Research Focus | Validation of cardiometabolic risk groups in older adults. |
| Study Group | Led by Robert Wagner, University Hospital Düsseldorf. |
| Study | Kora F4 study (Augsburg region) |
| Participants | 843 participants aged 61-82 without diabetes. |
| Key Finding | six previously identified risk groups remain relevant in older populations |
| Publication | Cardiovascular Diabetology, 2025 (DOI: 10.1186/S1293-025-02617-8) |